000 | 01166 a2200301 4500 | ||
---|---|---|---|
005 | 20250513191956.0 | ||
264 | 0 | _c19991021 | |
008 | 199910s 0 0 eng d | ||
022 | _a1084-2764 | ||
024 | 7 |
_a10.1053/siic.1999.0091 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerguson, J J | |
245 | 0 | 0 |
_aSafety of the use of IIb/IIIa receptor blockers with or without the use of other anticoagulants. _h[electronic resource] |
260 |
_bSeminars in interventional cardiology : SIIC _cJun 1999 |
||
300 |
_a97-102 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCoronary Disease _xblood |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 | _aSafety |
700 | 1 | _aLau, T K | |
773 | 0 |
_tSeminars in interventional cardiology : SIIC _gvol. 4 _gno. 2 _gp. 97-102 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/siic.1999.0091 _zAvailable from publisher's website |
999 |
_c10431335 _d10431335 |